About the Gonorrhea Diagnostics Market
Gonorrhea is a sexually transmitted disease that can affect both males and females. It is caused by the bacterium Neisseria gonorrhoeae. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes, and urethra. It can also grow and infect the throat, mouth, and anus. Women are more likely to contract this disease than men. Based on the Sexually Transmitted Disease Surveillance 2009 report, the Centers for Disease Control and Prevention (CDC) estimated that gonorrhea is the second most common communicable disease in the US.
Technavio’s analysts forecast the global gonorrhea diagnostics market to grow at a CAGR of 9.25% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global gonorrhea diagnostics market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of gonorrhea diagnostics products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Gonorrhea Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.
Key vendors
• Abbott Laboratories
• Beckman Coulter
• Roche Diagnostics
• Siemens
Other prominent vendors
• Agilent Technologies
• Alere
• Becton Dickinson and Company
• Bio-Rad
• Cepheid
• Diamedix
• Kyowa Medex
• Lonza
• Mackay Life Sciences
• Nihon Kohden
• Ortho-Clinical Diagnostics
• Polymedco
• Qiagen
• SDIX
• Sequenom
• Sienco
• Sysmex
• Takara Bio
• Thermo Fisher
Market driver
• Increase incidence of gonorrhea
• For a full, detailed list, view our report
Market challenge
• Lack of technical expertise
• For a full, detailed list, view our report
Market trend
• Growing use of molecular diagnostics
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Gonorrhea: An overview
• Etiology of gonorrhea
• Symptoms and incubation period of gonorrhea
• Methods of collection of specimens for the diagnosis of gonorrhea
• Complications of untreated gonorrhea
• Patient counselling
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Cost analysis
PART 07: Market segmentation by application
• Chromatography
• Diagnostic imaging
• Differential light scattering
• Flow cytometry
• Gel microdroplets
• Immunoassay
• Molecular diagnostics
• Monoclonal antibodies test
PART 08: Geographical segmentation
• Gonorrhea diagnostics market in Americas
• Gonorrhea diagnostics market in EMEA
• Gonorrhea diagnostics market in APAC
PART 09: Key leading countries
• US
• Germany
• Japan
PART 10: Buying criteria
• Key
PART 11: Market drivers
• Increase in incidence of gonorrhea
• Significant growth in emerging countries
• Increase in patient awareness
• Improvement in healthcare infrastructure
PART 12: Impact of drivers
PART 13: Market challenges
• Issues in regulatory framework
• Intense competition among vendors
• Lack of technical expertise
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Technological advancements
• Growing use of molecular diagnostics
• Increase in M&A
PART 16: Vendor landscape
• Competitive scenario
PART 17: Key vendor analysis
• Abbott Laboratories
• Beckman Coulter
• Roche Diagnostics
• Siemens
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Symptoms and incubation period of gonorrhea
Exhibit 03: Average duration of infection for gonorrhea
Exhibit 04: Methods of collection of specimens in different
PARTs of the body
Exhibit 05: Complications of untreated gonorrhea
Exhibit 06: Patient counselling
Exhibit 07: Global gonorrhea diagnostics market 2015-2020 in ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Segmentation of global gonorrhea diagnostics market based on the application
Exhibit 10: Global gonorrhea diagnostics market 2015 (%)
Exhibit 11: Global gonorrhea diagnostics market 2020 (%)
Exhibit 12: Gonorrhea diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 13: Gonorrhea diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 14: Gonorrhea diagnostics market in APAC 2015-2020 ($ billions)
Exhibit 15: Global gonorrhea diagnostics market by geography 2015-2020 ($ millions)
Exhibit 16: Global gonorrhea diagnostics market by geography (%)
Exhibit 17: Reported cases of gonorrhea based on age group in US in 2014 (CDC)
Exhibit 18: Rates of reported cases of gonorrhea by age and gender in US 2014
Exhibit 19: Reported cases of gonorrhea in US from 2010-2014 (in thousands)
Exhibit 20: Reported cases of gonorrhea among women in US 2010-2014
Exhibit 21: Reported cases of gonorrhea among men 2010-2014
Exhibit 22: Buying criteria for global gonorrhea diagnostics market
Exhibit 23: Impact of drivers
Exhibit 24: Impact of drivers and challenges
Exhibit 25: Abbott Laboratories: Product portfolio
Exhibit 26: Abbott Laboratories: Diagnostic segment by revenue 2013-2015 ($ billions)
Exhibit 27: Abbott Laboratories: Key takeaways
Exhibit 28: Product portfolio
Exhibit 29: Beckman Coulter: Key takeaways
Exhibit 30: Product portfolio
Exhibit 31: Molecular diagnostics 2013-2015 ($ billions)
Exhibit 32: Roche Diagnostics: Key takeaways
Exhibit 33: Product portfolio
Exhibit 34: Siemens: Healthcare segment by revenue 2013-2015 ($ billions)
Exhibit 35: Siemens: Key takeaways
